About:
Jubilant Ingrevia was Demerged from Jubilant Lifesciences in February 2021. It is in the business of Speciality chemicals, Animal & human nutrition, life science chemicals, ethanol etc.
- Stock is in a continuous uptrend.
- Price today crossed the previous swing high after forming a base at Support Level (which was earlier a resistance)
- Price broke out with good volumes with good accumulation activity at the end of July.
- Spread chart also gave a breakout of the previous swing high.
Financial Results:
- Jubilant's QoQ Sales growth is 67%
- QoQ Profit growth is 211%
Jubilant Ingrevia is looking financially & technically sound. It looks good for positional investment.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款阅读更多信息。